KRAS and colorectal carcinoma: Moreover, a statistically significant association was observed between MLH1 promoter methylation and KRAS mutation in MSI CRC (OR = 0.340; 95% CI: 0.167–0.693; P = 0.003; I2 = 0.000%) (Table 3).